Log In
Print this Print this

eluxadoline (Viberzi) (JNJ-270189066)

Also known as: MuDelta

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionLocally acting mu opioid receptor (MOR; OPRM1) agonist and delta opioid receptor antagonist
Molecular Target Mu opioid receptor (MOR) (OPRM1) ; Opioid receptor delta 1 (OPRD1) (DOR)
Mechanism of ActionMu opioid receptor agonist; Delta opioid receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat diarrhea-predominant irritable bowel syndrome (IBS-D)
Regulatory Designation U.S. - Fast Track (Treat diarrhea-predominant irritable bowel syndrome (IBS-D));
U.S. - Priority Review (Treat diarrhea-predominant irritable bowel syndrome (IBS-D))
Partner Allergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today